SAMBATARO, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 3.126
AS - Asia 2.275
EU - Europa 1.050
SA - Sud America 318
AF - Africa 298
OC - Oceania 1
Totale 7.068
Nazione #
US - Stati Uniti d'America 3.083
SG - Singapore 901
CN - Cina 872
IT - Italia 485
BR - Brasile 277
CI - Costa d'Avorio 228
KR - Corea 219
IE - Irlanda 177
DE - Germania 122
VN - Vietnam 118
FI - Finlandia 72
IN - India 68
GB - Regno Unito 46
RU - Federazione Russa 35
CA - Canada 27
AR - Argentina 25
BJ - Benin 22
NL - Olanda 22
FR - Francia 20
JP - Giappone 19
SN - Senegal 18
BD - Bangladesh 17
UA - Ucraina 13
CZ - Repubblica Ceca 11
MX - Messico 11
PL - Polonia 11
SE - Svezia 10
ZA - Sudafrica 10
HK - Hong Kong 8
ID - Indonesia 8
IR - Iran 8
NG - Nigeria 8
EC - Ecuador 6
TR - Turchia 6
AT - Austria 5
BE - Belgio 5
ES - Italia 5
MA - Marocco 5
CO - Colombia 4
IQ - Iraq 4
PK - Pakistan 4
CH - Svizzera 3
CL - Cile 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
CY - Cipro 2
GR - Grecia 2
KE - Kenya 2
LB - Libano 2
LT - Lituania 2
NP - Nepal 2
PY - Paraguay 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TL - Timor Orientale 1
TN - Tunisia 1
VE - Venezuela 1
Totale 7.068
Città #
Dallas 704
Santa Clara 702
Singapore 481
Hefei 443
Abidjan 228
Chicago 228
Seoul 219
Chandler 218
Dublin 177
Los Angeles 165
Ashburn 123
Boardman 120
Munich 105
Beijing 99
Catania 76
Civitanova Marche 72
Kochi 51
New York 49
Palermo 37
Ho Chi Minh City 36
Cambridge 34
Helsinki 34
Lawrence 34
Andover 32
Buffalo 30
Hanoi 24
Lappeenranta 23
Cotonou 22
Des Moines 22
Dong Ket 20
Dakar 18
Milan 18
Amsterdam 17
San Francisco 16
São Paulo 16
Messina 14
Nanjing 14
Jacksonville 13
Brooklyn 12
Tokyo 12
Wilmington 12
Phoenix 11
Bremen 10
Montreal 10
San Giovanni la Punta 10
Ferentino 9
Toronto 9
Turku 9
Warsaw 9
Abuja 8
Johannesburg 8
Reggio Emilia 8
Seattle 8
Shanghai 8
Stockholm 8
Tehran 8
Woodbridge 8
Bari 7
Brno 7
Falls Church 7
Hong Kong 7
Council Bluffs 6
Denver 6
London 6
Manchester 6
Porto Alegre 6
Rome 6
Saint Petersburg 6
The Dalles 6
Washington 6
Boston 5
Charlotte 5
Columbus 5
Dhaka 5
Guangzhou 5
Guarulhos 5
Haiphong 5
Houston 5
Paris 5
Rio de Janeiro 5
Assago 4
Casablanca 4
Changsha 4
Chennai 4
Forlì 4
Hirosaki 4
Jyväskylä 4
Latina 4
Nuremberg 4
Pennisi 4
Poplar 4
Redondo Beach 4
São Bernardo do Campo 4
Turin 4
Uberlândia 4
Atlanta 3
Bauru 3
Belpasso 3
Betim 3
Brasília 3
Totale 5.118
Nome #
Pulmonary Vasculitides: A Radiological Review Emphasizing Parenchymal HRCT Features 229
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes 158
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies 117
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 114
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 109
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 107
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists 105
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 104
INVOLVEMENT OF OXIDATIVE STRESS AND VITAMINS D,C AND A IN SYSTEMIC SCLEROSIS: IN RELATION TO CLINICAL DISEASE ACTIVITY PARAMETERS 103
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 101
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis 98
Comorbidities of IPF: How do they impact on prognosis 95
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them? 95
"Usual" interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 95
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series 94
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 90
COMPARISON BETWEEN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES: A PROSPECTIVE COHORT 89
Reduction of carotid baroreceptor sensitivity in systemic sclerosis 88
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 88
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT 87
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases 85
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT 85
Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification 85
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 84
Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study 83
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome 83
Radiological Insights into UIP Pattern: A Comparison Between IPF and Non-IPF Patients 80
Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients 79
The Impaired Elasticity of Large Arteries in Systemic Sclerosis Patients 78
The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features 78
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis 76
Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology 76
Heart Valve Abnormalities in Systemic Sclerosis Patients: A Multicenter Cohort Study and Review of the Literature 75
Developing PI3K Inhibitors for Respiratory Diseases 74
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 74
Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis 72
Rethinking the need for increased clinical and radiological awareness of incidentally discovered interstitial lung abnormalities on CT chest 71
Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes 71
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: currentissues and future perspectives 70
Systemic Sclerosis and Idiopathic Portal Hypertension: Report of a Case and Review of the Literature 69
Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study 67
Calcineurin inhibitor-based immunosuppression and COVID-19: Results from a multidisciplinary cohort of patients in Northern Italy 67
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases 65
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 64
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 63
Point of care antibody detection assays for past SARS-CoV-2 infection are accurate over the time 63
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? Reply 63
Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis 62
Vitamin D Impacts on Skeletal Muscle Dysfunction in Patients with COPD Promoting Mitochondrial Health 62
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the {COVAD} surveys 61
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 60
Eosinophilic Interstitial Pneumonia 60
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? 59
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 59
Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea 59
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol 58
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 58
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State 57
Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis 57
Quantification of ground glass opacities can be useful to describe disease activity in systemic sclerosis 56
Interstitial Pneumonia with Autoimmune Features (IPAF): time to redefine the classification criteria 55
Present and future of biologic drugs in primary Sjögren’s syndrome 55
Highlights on Future Treatments of IPF: Clues and Pitfalls 54
Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19: A multicentric prospective evaluation 53
Tumoural calcinosis of the spine in the course of systemic sclerosis: Report of a new case and review of the literature 53
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives 53
Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies 53
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 53
A die-hard giant capillary 53
Systemic lupus erythematosus patients with and without neuropsychiatric manifestations: a neck and transcranial duplex sonography study 52
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 52
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 52
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 52
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 51
NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: A comparison with the proposed composite indices for this disease status entity 51
Impact of {COVID}-19 outbreak in an Italian cohort of patients with systemic sclerosis 51
The Pattern and Progression of "Usual" Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 51
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 51
{COVAD} survey 2 long-term outcomes: unmet need and protocol 49
Direct-acting Antivirals Inducing HCV-RNA Sustained Suppression Improve Xerophthalmia in HCV-infected Patients 49
Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases 48
Interstitial lung disease and anti-myeloperoxidase antibodies: Not a simple association 48
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 47
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies 46
Autoimmunity in Interstitial Lung Disease 46
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 45
High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis 45
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 45
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 44
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 43
The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: A validation study of the NEMO score 43
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 43
Subclinical carotid atherosclerosis in elderly patients with primary Sjögren syndrome: a duplex Doppler sonographic study 42
Quantitative chest tomography indexes are related to disease activity in systemic sclerosis: results from a cross-sectional study 42
Reply to J. Magalon et al 41
Letter to editor: “Interstitial pneumonia with autoimmune features: Clinical, radiologic and histological characteristics and outcome in a series of 57 patients” 41
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis from the CLASS project 41
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 39
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study 39
Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases 38
Totale 6.843
Categoria #
all - tutte 28.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 50 6 21 3 18 2 4 16
2021/2022234 6 38 3 16 43 6 36 11 6 6 3 60
2022/2023688 37 55 6 63 68 93 21 110 150 16 41 28
2023/2024655 24 72 83 34 31 136 4 28 6 43 104 90
2024/20252.656 45 352 127 177 479 405 116 63 167 174 277 274
2025/20262.743 388 737 901 296 421 0 0 0 0 0 0 0
Totale 7.244